Summary#
S. Res. 464 is a Senate resolution, not a bill that changes federal law. The Senate agreed to it on October 23, 2025; it designated September 2025 as “National Cholesterol Education Month” and September 30, 2025, as “LDL-C Awareness Day.” Its stated goal was to encourage awareness of LDL-C and the need to screen for and treat high levels.
- The resolution encourages people in the United States to know their LDL-C number; it does not require them to get tested.
- It recognizes the need to screen for and treat elevated LDL-C, but does not require health care providers to offer tests or treatment.
- The dates it designates have passed. The resolution creates no ongoing program, benefit, enforcement power, or new office.
What it means for you#
- Individuals: The Senate encouraged you to know your LDL-C number. The resolution does not require a test or change your access to health care.
- Health care providers and insurers: The resolution creates no new testing, treatment, coverage, or reporting requirements.
- Taxpayers: The resolution does not appropriate money or create a fee or tax.
Money#
No cost information is in the available material. The resolution itself does not authorize spending.
- The resolution sets no funding, staffing, or implementation requirements.
- Costs, if any, related to activities outside the resolution are not specified. No publicly available information.
What is unclear#
- The resolution does not set out any actions or measures to carry out its awareness goal.
- It does not say who, if anyone, would organize awareness activities or how they would be funded.
- It does not create a process to expand testing or treatment, or explain how existing efforts would change.
Case for#
- The resolution draws attention to LDL-C as a risk factor for cardiovascular disease and encourages people to know their number.
- Its preamble points to gaps in testing and in reaching recommended LDL-C levels, including among some people after a heart attack.
- A possible argument for an awareness designation is that it can focus attention on screening and treatment without imposing new requirements.
Case against#
- The resolution does not require screening, treatment, insurance coverage, or follow-up care, so it does not directly address the gaps described in its preamble.
- It does not provide funding or assign responsibility for awareness activities.
- The designated dates have passed, and the resolution specifies no continuing actions or results.